Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Tax Provisions (2023)

Historic Tax Provisions for Mereo BioPharma (MREO) over the last 1 years, with Q4 2023 value amounting to -$532000.0.

  • Mereo BioPharma's Tax Provisions changed N/A to -$532000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$532000.0, marking a year-over-year change of. This contributed to the annual value of -$532000.0 for FY2023, which is 2590.53% up from last year.
  • Latest data reveals that Mereo BioPharma reported Tax Provisions of -$532000.0 as of Q4 2023.
  • Mereo BioPharma's 5-year Tax Provisions high stood at -$532000.0 for Q4 2023, and its period low was -$532000.0 during Q4 2023.